Progen Pharmaceuticals Ltd (PGLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PGLA | BOLT | CMMB | ||
| Company | Progen Pharmaceuticals Ltd | Bolt Biotherapeutics Inc | Chemomab Therapeutics Ltd ADR | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 0.1650 | 4.91 | 1.4700 | ||
| High | 0.1650 | 5.01 | 1.5600 | ||
| Low | 0.1650 | 4.52 | 1.3600 | ||
| Latest | 0.1650 | 4.63 | 1.5500 | ||
| Change | unch | -0.27 | +0.1100 | ||
| % Change | unch | -5.51% | +7.64% | ||
| Volume | 4,500 | 51,561 | 231,037 | ||
| 20-Day Average Volume | 1,695 | 34,643 | 105,892 | ||
| Previous Close | 0.1650 | 4.90 | 1.4400 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.1951 | 5.26 | 1.5520 | ||
| 20-Day Raw Stochastic | 0.00% | 13.19% | 51.28% | ||
| 20-Day Relative Strength | 44.31 | 40.04 | 44.57 | ||
| Weighted Alpha | +35.51 | -47.54 | -76.02 | ||
| Today's Opinion | N/A | 64% Sell | 100% Sell | ||
| Previous Opinion | N/A | 64% Sell | 100% Sell | ||
| Last Month's Opinion | N/A | 56% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -21.43% since 09/30/16 | -9.75% since 02/19/26 | -5.49% since 02/19/26 | ||
| Low | 0.1650 on 10/26/16 | 4.52 on 02/26/26 | 1.3500 on 02/25/26 | ||
| High | 0.1650 on 10/26/16 | 5.30 on 02/20/26 | 1.6100 on 02/20/26 | ||
| 1-Month | |||||
| %Chg | -9.84% since 09/22/16 | -29.31% since 01/26/26 | -11.93% since 01/26/26 | ||
| Low | 0.1650 on 10/26/16 | 4.27 on 02/18/26 | 1.3500 on 02/25/26 | ||
| High | 0.2100 on 09/30/16 | 7.11 on 01/28/26 | 1.8200 on 01/27/26 | ||
| 3-Month | |||||
| %Chg | -18.44% since 07/25/16 | -6.46% since 11/26/25 | -38.74% since 11/26/25 | ||
| Low | 0.1650 on 10/26/16 | 4.27 on 02/18/26 | 1.3500 on 02/25/26 | ||
| High | 0.2100 on 09/30/16 | 7.20 on 01/16/26 | 2.7700 on 12/08/25 | ||
| 6-Month | |||||
| %Chg | -28.26% since 04/18/16 | -13.30% since 08/26/25 | -54.41% since 08/26/25 | ||
| Low | 0.1350 on 04/28/16 | 4.27 on 02/18/26 | 1.3500 on 02/25/26 | ||
| High | 0.2150 on 06/06/16 | 7.20 on 01/16/26 | 3.7800 on 08/27/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 9,120 | 9,405 | 8,863 | ||
| Shares Outstanding, K | 55,290 | 1,919 | 6,155 | ||
| Annual Sales | 2,390,000 | 7,690,000 | 0 | ||
| Annual Net Income | -9,040,000 | -63,120,000 | -13,950,000 | ||
| Last Quarter Sales | N/A | 2,170,000 | 0 | ||
| Last Quarter Net Income | N/A | -7,140,000 | -1,740,000 | ||
| 60-Month Beta | 0.04 | 0.92 | 0.56 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -3.72 on 11/12/25 | -0.36 on 08/14/25 | ||
| Latest Earnings Date | 12/31/69 | 03/23/26 | 03/02/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | 08/29/14 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||